Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Curcuminoids in neurodegenerative diseases.

Kim DS, Kim JY, Han Y.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):184-204. Review.

PMID:
22742420
2.

Curcumin and neurodegenerative diseases: a perspective.

Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ.

Expert Opin Investig Drugs. 2012 Aug;21(8):1123-40. doi: 10.1517/13543784.2012.693479. Review.

PMID:
22668065
3.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
4.

The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

Joshi G, Johnson JA.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):218-29. Review.

5.

Metals, oxidative stress and neurodegenerative disorders.

Jomova K, Vondrakova D, Lawson M, Valko M.

Mol Cell Biochem. 2010 Dec;345(1-2):91-104. doi: 10.1007/s11010-010-0563-x. Review.

PMID:
20730621
6.

New therapeutic strategy for Parkinson's and Alzheimer's disease.

Esposito E, Cuzzocrea S.

Curr Med Chem. 2010;17(25):2764-74. Review.

PMID:
20586718
7.

Therapeutic antioxidants for neurodegenerative disease.

Linseman DA.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):183. No abstract available.

PMID:
22857712
8.

Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.

Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB.

Neurosignals. 2005;14(1-2):46-60. Review.

PMID:
15956814
9.

An update on pharmacological approaches to neurodegenerative diseases.

Scatena R, Martorana GE, Bottoni P, Botta G, Pastore P, Giardina B.

Expert Opin Investig Drugs. 2007 Jan;16(1):59-72. Review.

PMID:
17155854
10.

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.

Hashimoto M, Rockenstein E, Crews L, Masliah E.

Neuromolecular Med. 2003;4(1-2):21-36. Review.

PMID:
14528050
11.

Ion channels on microglia: therapeutic targets for neuroprotection.

Skaper SD.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):44-56. Review.

PMID:
21143139
13.

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, Hardeland R, Cardinali DP.

Neurotox Res. 2013 Apr;23(3):267-300. doi: 10.1007/s12640-012-9337-4. Review.

PMID:
22739839
14.

The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease.

Campos HC, da Rocha MD, Viegas FP, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, Viegas C Jr.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):239-50. Review.

PMID:
20874702
15.

In the rush for green gold: Can green tea delay age-progressive brain neurodegeneration?

Mandel SA, Youdim MB.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):205-17. Review.

PMID:
22742421
16.

Apoptosis modulators in the therapy of neurodegenerative diseases.

Deigner HP, Haberkorn U, Kinscherf R.

Expert Opin Investig Drugs. 2000 Apr;9(4):747-64. Review.

PMID:
11060707
17.

Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration.

Wang L, Ankati H, Akubathini SK, Balderamos M, Storey CA, Patel AV, Price V, Kretzschmar D, Biehl ER, D'Mello SR.

J Neurosci Res. 2010 Jul;88(9):1970-84. doi: 10.1002/jnr.22352.

PMID:
20143421
18.

The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease.

da Rocha MD, Viegas FP, Campos HC, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, Viegas C Jr.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):251-70. Review.

PMID:
20874701
19.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Maccioni RB, Muñoz JP, Barbeito L.

Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.

PMID:
11578751
20.
Items per page

Supplemental Content

Support Center